Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-21 · accession 0001600620-24-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-22 | 2024-05-21 | AUPH | Jayne David R.W. | Dir | S - Sale | $5.74 | -4,946 | 44.4K | -10% | -$28.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | S | D | 4,946 | $5.74 | 44,364 | D | — | — | (F1) Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023. |